PATEO CONNECT Technology (Shanghai) Corporation 博 泰 車 聯 網 科 技 ( 上 海 ) 股 份 有 限 公 司 （ 於 中 華 人 民 共 和 國 成 立 的 股 份 有 限 公 司 ） （股份代號：2889） 董事名單與其角色和職能 獨立非執行董事 李遠鵬博士 龐春霖先生 張曉亮先生 劉功申博士 徐黎黎女士 博泰車聯網科技（上海）股份有限公司（「本公司」）董事（「董事」）會（「董事會」） 成員載列如下： 執行董事 應臻愷先生 （本公司董事會主席兼總經理） 張富凱先生 徐真慧女士 賴偉林先生 高穎輝先生 非執行董事 王碧輝先生 馬曉詠先生 – 1 – 董事會設立三個委員會。下表提供該等委員會的成員資料。 | 董事 | 董事委員會 | 審計委員會 | 提名委員會 | 薪酬委員會 | | --- | --- | --- | --- | --- | | 應臻愷先生 | | | | M | | 張富凱先生 | | | | | | 徐真慧女士 | | | M | | | 賴偉林先生 | | | | | | 高穎輝先生 | | | | | | 王碧輝先生 | | | | ...

博 泰 車 聯 網 科 技 ( 上 海 ) 股 份 有 限 公 司 （ 於 中 華 人 民 共 和 國 成 立 的 股 份 有 限 公 司 ） （股份代號：2889） 董事辭任； 建議委任獨立非執行董事；及 薪酬委員會組成變動 董事辭任 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部份內容而產生或因 倚賴該等內容而引致之任何損失承擔任何責任。 PATEO CONNECT Technology (Shanghai) Corporation 博泰車聯網科技（上海）股份有限公司（「本公司」）董事（「董事」）會（「董事會」） 宣佈，因工作安排，王延峰博士（「王博士」）於2025年12月23日向本公司提出辭 任本公司獨立非執行董事、董事會薪酬委員會主席職務，自2025年12月23日起 生效。 王博士已確認，其與董事會之間並無意見分歧，且並無有關其辭任的事宜須提 呈本公司股東（「股東」）或香港聯合交易所有限公司（「聯交所」）垂注。 董事會謹此對王博士於任職期間對本公司的貢獻表示衷心感謝。 董事會宣佈，因工作安排，王越先生（ ...

公司"全栈技术+产品高端化+生态协同"三重协同实现业内竞争领先 智能座舱解决方案营收占比稳固，盈利方面，2024年毛利润3.01亿元(同比+30.3%)。盈利持续改善，核 心源于三大支柱：1)全栈技术筑壁垒：自研"软件+硬件+云端"一体化方案，支持"一车一方案"；截至 2024年累计专利超6000件(发明专利占比80%)，2022-2024年研发投入超7亿元，截至2025年5月末研发团 队规模达709人。2)产品高端化：国内搭载高通8295芯片的高端智能座舱解决方案定点数量居国内首 位，新一代骁龙8397平台方案已获中国头部车企量产定点；同时为少数提供麒麟9610A+鸿蒙方案的供 应商，若华为"鸿蒙智行"车型26-27年放量出货，公司有望深度受益。3)生态协同强赋能：股东涵盖天 津金米(背后控股方为小米，持股5.17%)、广州平安(持股3.89%)等，形成"车企订单+生态资源+金融支 持"协同网络。 盈利预测与估值 该行预测公司2025-2027年营收分别为35.84亿元、56.64亿元、87.61亿元人民币，同比增长40%、58%、 55%，对应2025-2027年PS分别为7.5x、4.7x、3.1x，公 ...

Group 1 - The core viewpoint of the report is that Botai Carlink (02889) is a leading supplier of smart cockpit solutions in China, with potential to penetrate the overseas OEM supply chain through international clients like Porsche, creating a second growth curve for overseas revenue [1][5] - Botai Carlink was established in 2009 and is set to be listed on the Hong Kong Stock Exchange in September 2025. It ranks third in China's passenger car smart cockpit domain control suppliers with a market share of 7.3% in 2024, and second in the new energy passenger car cockpit domain control market with a market share of 13.11% in the first half of 2025 [2] - The smart cockpit industry in China is projected to grow from 129 billion yuan in 2024 to 299.5 billion yuan by 2029, with a CAGR of 18.4%, indicating significant growth potential and a shift towards high-end solutions [3] Group 2 - Botai Carlink's revenue structure is improving, with smart cockpit solutions accounting for 95.5% of revenue in 2024 and 95.7% in the first half of 2025, while network service revenue remains minimal [2] - The company is expected to achieve a gross profit of 301 million yuan in 2024, reflecting a year-on-year increase of 30.3%, driven by its three pillars: full-stack technology, product high-endization, and ecological collaboration [4] - Revenue forecasts for Botai Carlink are 3.584 billion yuan, 5.664 billion yuan, and 8.761 billion yuan for 2025 to 2027, representing year-on-year growth rates of 40%, 58%, and 55% respectively, with a projected PS valuation higher than the average of comparable companies [5]

Group 1: Medical Isotope Production - China National Nuclear Corporation (CNNC) has successfully developed a complete technology chain for the irradiation preparation of iodine-131, enhancing the self-sufficiency of medical isotopes in China [1] - The technology includes the preparation of precursor isotopes, reactor irradiation, and nuclear drug development, forming an environmentally friendly and autonomous industrial chain [1] - The successful production of high-purity tellurium-130 isotopes with over 99% abundance fills a gap in the domestic large-scale preparation of high-purity enriched tellurium isotopes [1] Group 2: Radiation Therapy Equipment and Drug Development - As of 2024, over 90 radiotherapy devices have been approved by the National Medical Products Administration, with more than 70% being domestic brands, significantly reducing reliance on imported equipment [2] - The development of new radiopharmaceuticals has accelerated, with over 200 pipelines entering clinical trials, introducing new isotopes like lutetium-177 and yttrium-90 for more precise cancer treatment options [2] Group 3: Corporate Transactions and Financial Updates - WuXi AppTec has completed the sale of its subsidiary, expecting a post-tax net profit of approximately 960 million yuan, which accounts for over 10% of the company's latest audited net profit attributable to shareholders [5][6] - Guolian Minsheng has terminated a 480 million yuan fund establishment transaction, with no adverse effects on the company's finances or shareholder rights [7] - Morning Paper Industry plans to sell all shares of a target company for 3.336 billion yuan [10] Group 4: New Technologies and Innovations - GAC Group's flying car, GOVY AirCab, has entered the airworthiness certification stage and is expected to be mass-produced by 2026, aiming to create a new mode of transportation that integrates air and ground travel [17] - China Tongyuan has signed a commercial cooperation agreement with Novartis for the radiopharmaceutical product, providing a new treatment option for advanced prostate cancer patients [18]

（股份代號：2889） 臨時股東會之代理人委任表格 與本代理人委任表格有關之 H股╱內資股數目 （註2） 本人╱吾等 （註3） ， 地址為 （註3） ， 為博泰車聯網科技（上海）股份有限公司（「本公司」） 股 （註2） H股╱內資股（註4） 的登記持有人， PATEO CONNECT Technology (Shanghai) Corporation 博 泰 車 聯 網 科 技 ( 上 海 ) 股 份 有 限 公 司 （ 於 中 華 人 民 共 和 國 成 立 的 股 份 有 限 公 司 ） 茲委任臨時股東會主席或 （註5） ， 地址為 ， 作為本人╱吾等 （註4） 之代理人，代表本人╱吾等 （註4） 出席本公司於2025年12月31日（星期三）上午10時正假座中國上海市虹口區東長治路 866號3701室本公司會議室舉行（「臨時股東會」）（及其任何續會），並按下列指示於該大會（及其任何續會）上就決議案進行投票，如果代 理人委任表格內並無作出任何指示，則本人╱吾等之代理人 （註4） 自行酌情投票。 | | 普通決議案 | （註6） 贊成 | （註6） 反對 | （註6） 棄權 | | --- | --- | - ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本通告之內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示概不就因本通告全部或任何部份內容而產生或因倚賴該等內容 而引致之任何損失承擔任何責任。 PATEO CONNECT Technology (Shanghai) Corporation 博 泰 車 聯 網 科 技 ( 上 海 ) 股 份 有 限 公 司 （ 於 中 華 人 民 共 和 國 成 立 的 股 份 有 限 公 司 ） （股份代號：2889） 臨時股東會通告 茲通告博泰車聯網科技（上海）股份有限公司（「本公司」）謹訂於謹訂於2025年12月 31日（星期三）上午10時正假座中國上海市虹口區東長治路866號3701室本公司會議室舉 行臨時股東會（「臨時股東會」），藉以審議並批准下列決議案： 普通決議案 1. 審議及批准關於取消監事會的議案。 特別決議案 1. 除文義另有所指外，本通告所用詞彙的涵義與本公司日期為2025年12月15日的與本通告有關的 通函內所界定者相同。 普通決議案 承董事會命 博泰車聯網科技（上海）股份有限公司 董事長 應臻愷 中國上海，2025年12月15日 – 1 ...

此乃要件 請即處理 閣下如對本通函任何方面或應採取之行動有任何疑問，應諮詢 閣下之持牌證券交易商或銀行經理、 律師、專業會計師或其他專業顧問。 閣下如已售出或轉讓所有名下之博泰車聯網科技（上海）股份有限公司股份，應立即將本通函連同隨 附之代理人委任表格送交買方或承讓人，或經手買賣或轉讓之銀行、持牌證券交易商或其他代理商， 以便轉交買方或承讓人。 香港交易及結算所有限公司及香港聯合交易所有限公司對本通函之內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示概不就因本通函全部或任何部份內容而產生或因倚賴該等內容 而引致之任何損失承擔任何責任。 PATEO CONNECT Technology (Shanghai) Corporation 博 泰 車 聯 網 科 技 ( 上 海 ) 股 份 有 限 公 司 （ 於 中 華 人 民 共 和 國 成 立 的 股 份 有 限 公 司 ） （股份代號：2889） (1) 建議取消監事會； (2) 建議修訂公司章程； (3) 建議修訂股東會議事規則； (4) 建議修訂董事會議事規則； (5) 建議修訂獨立非執行董事工作制度； (6) 建議調整獨立非執行董事薪酬； 及 ...

Company News - China Shenhua (01088.HK) reported coal sales of 389.5 million tons for the first 11 months, a decrease of 7.7% year-on-year. November sales were 37 million tons, down 3.6% year-on-year [1] - China Metallurgical Group (01618.HK) signed new contracts worth RMB 958.13 billion in the first 11 months, an 8.6% decrease year-on-year, with overseas contracts amounting to RMB 75 billion, a 0.4% increase year-on-year [1] - China Eastern Airlines (00670.HK) saw a 6.51% year-on-year increase in passenger capacity in November, with passenger turnover up 10.35% year-on-year and a seat load factor of 87.37%, up 3.04 percentage points year-on-year [1] - China Southern Airlines (01055.HK) reported an 8.68% year-on-year increase in passenger capacity in November, with passenger turnover up 10.42% year-on-year and a seat load factor of 86.29%, up 1.36 percentage points year-on-year [1] - New China Life Insurance (01336.HK) recorded cumulative original insurance premium income of RMB 188.85 billion for the first 11 months, a 16% year-on-year increase [1] - AOS Group (01161.HK) announced annual results for the year ending September 30, 2025, with revenue of approximately HKD 981 million, a decrease of 0.19% year-on-year, and a net profit of HKD 80.887 million, a 19% year-on-year increase [1] - Hopson Development Holdings (00754.HK) reported total contract sales of approximately RMB 14.27 billion for the first 11 months, an 8.91% decrease year-on-year [1] - Agile Group (01813.HK) had a pre-sale amount of RMB 511 million in November, a decrease of 21.4% year-on-year [1] - Galen Pharmaceuticals (01672.HK) is expected to become a best-in-class oral small molecule IL-17 inhibitor, with positive topline results from its Phase I study in the U.S. [1] - Bole Technology (02592.HK) submitted a new drug clinical trial application for CBT-199 to the U.S. FDA [1] - China Supply Chain Industry (03708.HK) signed a strategic cooperation framework agreement with Golden Energy regarding digital assets [1] - Times China Holdings (01233.HK) had its liquidation petition withdrawn [1] - Botai Car Union (02889.HK) received a first project designation notice from a leading domestic new energy vehicle client [1] Buyback Activities - Haijia Medical (06078.HK) plans to repurchase 10% of its issued shares, with a repurchase amount of no less than RMB 300 million [1] - Tencent Holdings (00700.HK) repurchased 1.051 million shares for HKD 636 million, with repurchase prices ranging from HKD 602.5 to HKD 608 [1] - Xiaomi Group (01810.HK) repurchased 7.2 million shares for HKD 302 million, with repurchase prices ranging from HKD 41.78 to HKD 42 [1] Share Cancellation - Pacific Shipping (02343.HK) canceled 23.739 million repurchased shares [2]

Core Viewpoint - The company, Botai Che Lian (02889.HK), has received its first project confirmation from a leading domestic electric vehicle client to provide a smart cockpit domain controller solution for its next-generation intelligent models, marking a significant milestone in its product offerings [1] Group 1: Project Development - The project confirmation represents the fourth high-end cockpit domain controller project awarded to the company since its listing [1] - This project highlights the company's ongoing efforts to deepen industry chain collaboration and enhance its ecological integration capabilities, which have gained widespread market recognition [1] Group 2: Market Position and Impact - The project confirmation signifies further market recognition of the company's technical integration and mass production delivery capabilities in the high-performance smart cockpit sector [1] - This development is expected to strengthen the company's competitive position within the smart automotive supply chain and positively impact its future operational growth [1]